Stacy L. Taylor is CLO & VP at Adaptive Biotechnologies Corp (ADPT). They have made 20 open-market trades across 1 company since 2020, most recently 2024-08-22.
CIK 0001799081
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 20 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADPT | 139,365 | $3.7M |
Shares reported on the most recent Form 4, priced at the 2024-08-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADPT | SELL · 10b5-1 | 2024-08-22 | 2024-08-23 | $4.50 | $121K | -12.1% | -13.9% | -11.7% |
| ADPT | SELL | 2024-03-05 | 2024-03-06 | $3.43 | $46K | -12.6% | -29.1% | -6.9% |
| ADPT | SELL | 2023-03-06 | 2023-03-08 | $8.59 | $277K | -9.0% | -2.6% | -12.7% |
| ADPT | SELL · 10b5-1 | 2022-03-08 | 2022-03-10 | $11.44 | $27K | +9.7% | -0.8% | -36.0% |
| ADPT | SELL | 2022-03-07 | 2022-03-08 | $12.01 | $19K | +5.6% | +8.7% | -43.9% |
| ADPT | SELL | 2021-12-22 | 2021-12-23 | $30.00 | $460K | -13.7% | -42.3% | -53.4% |
| ADPT | SELL · 10b5-1 | 2021-09-07 | 2021-09-09 | $40.00 | $20K | +0.2% | -18.4% | -25.6% |
| ADPT | SELL | 2021-06-30 | 2021-07-01 | $41.39 | $329K | -14.8% | -8.1% | -18.9% |
| ADPT | SELL | 2021-06-17 | 2021-06-21 | $40.00 | $167K | -0.0% | -4.3% | -5.4% |
| ADPT | SELL | 2021-04-30 | 2021-05-03 | $41.93 | $349K | -10.6% | -1.2% | -2.1% |
| ADPT | SELL | 2021-03-31 | 2021-04-02 | $40.00 | $167K | +3.4% | -7.7% | -3.2% |
| ADPT | SELL | 2021-02-26 | 2021-03-01 | $55.53 | $290K | -21.2% | -26.8% | -33.4% |
| ADPT | SELL | 2021-02-16 | 2021-02-17 | $64.64 | $2.0M | -5.4% | -31.6% | -42.4% |
| ADPT | SELL | 2021-01-29 | 2021-02-01 | $56.35 | $282K | +11.2% | -13.3% | -34.3% |
| ADPT | SELL | 2020-12-31 | 2020-12-31 | $57.73 | $638K | +7.1% | -5.2% | -32.1% |
| ADPT | SELL | 2020-11-23 | 2020-11-24 | $46.31 | $266K | +18.2% | +38.4% | +25.6% |
| ADPT | SELL | 2020-10-26 | 2020-10-28 | $49.86 | $256K | -6.1% | -8.2% | +21.3% |
| ADPT | SELL | 2020-09-24 | 2020-09-28 | $47.69 | $246K | +4.3% | +4.7% | +25.3% |
| ADPT | SELL | 2020-08-24 | 2020-08-24 | $42.43 | $176K | -11.8% | +15.7% | +10.0% |
| ADPT | SELL | 2020-07-24 | 2020-07-24 | $36.03 | $208K | +8.5% | +13.4% | +27.9% |
| ADPT | SELL | 2020-06-24 | 2020-06-25 | $46.68 | $269K | +2.9% | -20.2% | +1.7% |
| ADPT | SELL | 2020-05-26 | 2020-05-28 | $42.00 | $121K | +6.6% | +18.2% | +5.4% |
| ADPT | SELL | 2020-04-27 | 2020-04-29 | $30.22 | $1.2M | +17.8% | +19.6% | +15.7% |
| ADPT | SELL · 10b5-1 | 2020-01-08 | 2020-02-18 | $30.00 | $20K | -12.9% | -30.1% | +21.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.